Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 IMMUNOSUPPRESSANTS
L04A IMMUNOSUPPRESSANTS
L04AC Interleukin inhibitors
L04AC02 Basiliximab
D03058 Basiliximab (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Immunological Agents
Immunosuppressants
Interleukin-2 Inhibitors
Basiliximab
D03058 Basiliximab (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
63 Biological preparations
639 Miscellaneous
6399 Others
D03058 Basiliximab (USAN/INN); Basiliximab (genetical recombination) (JAN)
Drug groups [BR:br08330]
Immunological agent
DG02019 Interleukin inhibitor
D03058 Basiliximab
Drug classes [BR:br08332]
Immunological agent
DG02019 Interleukin inhibitor
D03058 Basiliximab
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
Interleukin receptors
IL2RA (CD25)
D03058 Basiliximab (USAN/INN) <JP/US>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D03058
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D03058
